Complimentary Shipping on all orders $100+
Cannabinoid Research
Peer-reviewed science
Cannabinoid Research
Cannabinoid science is evolving quickly. Every year, researchers uncover new ways these hemp-derived compounds interact with inflammation pathways, neurological signaling, mood regulation, skin health, and the body's own stress-response systems.
The studies below are curated peer-reviewed research exploring the therapeutic potential of CBD, CBG, CBC, CBN, and other minor cannabinoids. These summaries are provided for educational purposes only and reflect ongoing scientific inquiry — not medical claims.
CBD
Cannabidiol research
- Cannabis Sativa L and non-psychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer
- Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
- Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders
- Cannabidiol (CBD) lowers diabetes incidence in mice
- Cannabinoids as aromatase inhibitors for anti-cancer activity
- Cannabinoid therapy in epilepsy
- Single cannabidiol (CBD) dose reduces blood pressure
- Cannabinoids for the treatment of ulcerative colitis (UC) and Crohn's disease (CD)
- Topical cannabinoid treatment of thumb basal joint arthritis
- A cross-sectional study of cannabidiol users
CBG
Cannabigerol research
CBN
Cannabinol research
- Preclinical study — CBN increases both REM and NREM sleep in rats
- CBN alleviates age-related cognitive decline (mouse model, 2025)
- 2024 review — CBN's pharmacological properties: pain, inflammation, neuroprotection, immune modulation, antimicrobial
- 2024 randomized controlled trial — 20 mg nightly CBN vs. placebo (human, sleep outcomes)
CBC
Cannabichromene research
CBDA & others